Female Libido Drug that Valeant Bought for $1 Billion Gets Mixed Reviews
Women taking Valeant Pharmaceuticals International Inc.’s pill Addyi, designed and approved to boost their sex drive, get one additional satisfying sexual experience every other month thanks to the medicine, according to a Dutch study.
The drug, which has failed to gain a sizable following since it was approved by U.S. regulators in August, also carries side effects including dizziness, sleepiness, nausea and fatigue, the study published in JAMA Internal Medicine found. Researchers from Erasmus University Medical Center in Rotterdam analyzed the combined results from eight clinical trials involving 5,914 women to draw their conclusions.
The drug, which has failed to gain a sizable following since it was approved by U.S. regulators in August, also carries side effects including dizziness, sleepiness, nausea and fatigue, the study published in JAMA Internal Medicine found. Researchers from Erasmus University Medical Center in Rotterdam analyzed the combined results from eight clinical trials involving 5,914 women to draw their conclusions.